


IFNAR2

Anti-IFNAR2 Products
- Recombinant Anti-human IFNAR2 Antibody (MOB-536)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: IgG
- Application: WB, Neut, FuncS
-
- Derivation: Human
- Species Reactivity: Human
- Type: IgG
- Application: ELISA, WB, IP, FuncS
-
- Species Reactivity: Human
- Application: ELISA, WB
-
- Species Reactivity: Human
- Type: Mouse IgG2a
- Application: Neut, FC, IHC, IP
- Recombinant Human Anti-human IFNAR2 Antibody Fab Fragment (MHH-536-F(E))
-
- Derivation: Human
- Species Reactivity: Human
- Type: Fab
- Application: IP, IF, Biosensors, FuncS
- Recombinant Human Anti-human IFNAR2 Antibody scFv Fragment (MHH-536-S(P))
-
- Derivation: Human
- Species Reactivity: Human
- Type: scFv
- Application: ELISA, WB, FuncS
- Recombinant Anti-human IFNAR2 Antibody Fab Fragment (MOB-536-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab
- Application: RIA, ELISA, FuncS
- Recombinant Anti-human IFNAR2 Antibody scFv Fragment (MOB-536-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: scFv
- Application: ELISA, WB, IF, FuncS
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB
- Anti-Mouse IFNAR2 Immunohistochemistry Kit (VS-0525-XY3411)
-
- Species Reactivity: Mouse
- Target: IFNAR2
- Application: IHC
- Chicken Anti-IFNAR2 Polyclonal IgY (BRD-0868MZ)
-
- Species Reactivity: Human
- Type: Chicken antibody
- Application: WB
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
Cancer-related genes, Disease related genes, FDA approved drug targets
Intracellular, Membrane, Secreted (different isoforms)
Cell type enhanced (Plasma cells)
Low immune cell specificity
Cell line enhanced (Karpas-707, U-266/70, U-266/84)
Heterodimer with IFNAR1 (PubMed:8181059, 7665574, 10049744, 24075985, 21854986). Interacts with the transcriptional factors STAT1 and STAT2 (PubMed:9121453, 28165510). Interacts with JAK1 (PubMed:8181059, 7759950). Interacts with USP18; indirectly via STAT2, it negatively regulates the assembly of the ternary interferon-IFNAR1-IFNAR2 complex and therefore type I interferon signaling (PubMed:28165510).
Receptor